[R21] Testing a new therapy for SPG4 Hereditary Spastic Paraplegia
Ente: National Institute of Neurological Disorders and Stroke
Scadenza: 2028-03-31
Importo max: $228,688
Paese: US
Descrizione
SUMMARY/ABSTRACT
Hereditary Spastic Paraplegia 4 (SPG4-HSP) is an underdiagnosed neurodegenerative disorder characterized
by progressive weakness and spasticity in both legs that escalate into wheelchair dependence. Symptoms result
mainly from dying-back degeneration of corticospinal tracts. The dis
Settori: National Institute of Neurological Disorders and Stroke
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.